Compare SGC & PROF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SGC | PROF |
|---|---|---|
| Founded | 1920 | N/A |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Apparel | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 181.8M | 243.2M |
| IPO Year | 1994 | 2017 |
| Metric | SGC | PROF |
|---|---|---|
| Price | $12.68 | $6.92 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 2 | 1 |
| Target Price | ★ $16.00 | $12.00 |
| AVG Volume (30 Days) | 32.9K | ★ 66.9K |
| Earning Date | 05-04-2026 | 05-07-2026 |
| Dividend Yield | ★ 4.93% | N/A |
| EPS Growth | N/A | ★ 25.89 |
| EPS | 0.06 | ★ 0.19 |
| Revenue | ★ $566,184,000.00 | $16,098,000.00 |
| Revenue This Year | $3.23 | $92.40 |
| Revenue Next Year | $3.82 | $64.10 |
| P/E Ratio | $208.50 | ★ $36.16 |
| Revenue Growth | 0.09 | ★ 50.73 |
| 52 Week Low | $8.30 | $3.92 |
| 52 Week High | $13.78 | $8.95 |
| Indicator | SGC | PROF |
|---|---|---|
| Relative Strength Index (RSI) | 67.63 | 51.19 |
| Support Level | $9.62 | $6.54 |
| Resistance Level | $13.01 | $7.07 |
| Average True Range (ATR) | 0.59 | 0.37 |
| MACD | 0.09 | -0.04 |
| Stochastic Oscillator | 99.72 | 24.43 |
Superior Group Of Companies Inc designs apparel products. The company operates through three segments: i) The Branded Products segment, under the brands BAMKO and HPI, produces and sells customized merchandising solutions, promotional products, and branded uniform programs. ii) The Healthcare Apparel segment, under the brands Wink and Fashion Seal Healthcare, manufactures and sells healthcare apparel including scrubs, lab coats, protective apparel, and patient garments. iii) The Contact Centers segment, through The Office Gurus entities, provides outsourced, nearshore, and onshore business process outsourcing (BPO), contact center, and call-center support services to customers in North America. The majority of the company's revenue is derived from the Branded Products segment.
Profound Medical Corp is a commercial-stage medical device company focused on the development and marketing of AI-powered, MRI-guided, incision-free therapies for the ablation of diseased tissue. The company's flagship product, the TULSA-PRO system, combines real-time MRI, robotically-driven transurethral sweeping action/thermal ultrasound and closed-loop temperature feedback control to ablate whole gland or physician defined region of malignant or benign prostate tissue. Its platform technologies combine imaging, robotic control, and ultrasound-based thermal ablation for the treatment of prostate conditions. The company generates revenue through the sale of capital equipment and recurring sales of single-use devices and related services used in patient treatments.